COST-EFFECTIVENESS OF DISEASE-MODIFYING TREATMENTS FOR MULTIPLE SCLEROSIS IN BULGARIA BASED ON EVIDENCE FROM REAL WORLD SETTINGS.

MLA

Dimitrova, Maria, et al. “Cost-Effectiveness of Disease-Modifying Treatments for Multiple Sclerosis in Bulgaria Based on Evidence from Real World Settings.” Farmacia, vol. 71, no. 6, Nov. 2023, pp. 1324–31. EBSCOhost, https://doi.org/10.31925/farmacia.2023.6.24.

APA

Dimitrova, M., Seitaridou, Y., Lazarova, R., Petrova, G., Mitov, K., Milanov, I., Marinov, L., Kamusheva, M., & Panayotov, P. (2023). Cost-Effectiveness of Disease-Modifying Treatments for Multiple Sclerosis in Bulgaria Based on Evidence from Real World Settings. Farmacia, 71(6), 1324–1331. https://doi.org/10.31925/farmacia.2023.6.24

Chicago

Dimitrova, Maria, Yoana Seitaridou, Rumyana Lazarova, Guenka Petrova, Konstantin Mitov, Ivan Milanov, Lyubomir Marinov, Maria Kamusheva, and Pavel Panayotov. 2023. “Cost-Effectiveness of Disease-Modifying Treatments for Multiple Sclerosis in Bulgaria Based on Evidence from Real World Settings.” Farmacia 71 (6): 1324–31. doi:10.31925/farmacia.2023.6.24.